Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/20/2021 73 14
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Jan/06/2021 8 0
Nitazoxanide Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/24/2020 5 1
BNT162b2 Emergency use authorization Experimental Vaccine Dec/11/2020 5 0
Amentoflavone Potential treatment - theoretical effect Natural product Antiviral Dec/10/2020 3 0
Agathisflavone Potential treatment - theoretical effect Natural product Antiviral Dec/10/2020 2 0
Itolizumab Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/25/2020 3 0
Vortioxetine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/25/2020 2 0
Fendiline HCl Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/25/2020 1 0
Monensin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/25/2020 2 0